Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults.

GUIDELINE TITLE
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults.

BIBLIOGRAPHIC SOURCE(S)
National Institute for Health and Clinical Excellence (NICE). Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Apr. 23 p. (Technology appraisal guidance; no. 170).

GUIDELINE STATUS
This is the current release of the guideline.

The guidance on this technology will be considered for review in February 2012.

abrir aquí para acceder al documento NGC AHRQ completo:
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults.